Frontiers in Physiology · 2020 · 12 citations · 33 references
MedicinePharmacologyPhysiologyCardiovascular PharmacotherapyPreventive CardiologyStructural Heart DiseaseBlood Pressure ManagementCardiovascular DiseaseFibrosisHypertension ManagementHypertensive Heart DiseaseCardiac Fibrosis ModulationHypertension PathophysiologyLeft Ventricular Mass IndexMechanisms Of Cardiac InjuryMyocardial ArchitectureMyocardial DegenerationMyocardial MicrostructureOrgan Fibrosis
Long-term hypertension can lead to both structural and functional impairments of myocardium. Reversing the left ventricular myocardial fibrosis has been considered as a key goal for curing chronic hypertension and has long been a hot field of research in recent years. The aim of the present work is to investigate the effect of electroacupuncture (EA) at PC6 on the hypertension induced myocardial fibrosis in spontaneously hypertensive rats (SHRs). Thirty SHRs were randomized into model, SHR + EA, and SHR + Sham EA group, with WKY rats as normal control. EA was applied once a day in 8 consecutive weeks. The cardiac fibrosis as well as the underlying mechanisms were investigated. After 8-weeks EA treatment at PC6, the enhanced myocardial fibrosis in SHRs were characterized by increased of the ratio of left ventricular mass index, collagen volume fraction, elevated content of hydroxyproline (Hyp), as well as the up-regulated expression of collagen I and collagen III in myocardium tissue of SHRs. All these abnormal alterations above in SHR + EA group was significantly lower compared to the model group. In addition, EA at PC6 significantly improved the pathological changes of myocardial morphology. Meanwhile, the increased levels of angiotensin II (Ang II), tumor necrosis factor-α (TNFα) and expression of transforming growth factor β1 (TGF-β1), connective tissue growth factor (CTGF), matrix metalloproteinase (MMP)-2, MMP-9 in serum or heart tissue of SHRs were also markedly diminished by EA. These results suggest that EA at bilateral PC6 could ameliorate the cardiac fibrosis in SHRs, which might be mediated by the regulation of Ang II - TGF-β1 pathway.
33
Myocardial Stiffness in Patients With Heart Failure and a Preserved Ejection Fraction
Michael R. Zile, Catalin F. Baicu, John S. Ikonomidis et al. · Circulation · 2015 · 666 citations
Mei Sun, Manyin Chen, Fayez Dawood et al. · Circulation · 2007 · 378 citations · Full text